All In Biotech

Free tool

FAERS Monitor: Cleviprex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022156 or its brand name (Cleviprex, Clevidipine). Reports on generic versions are filed under their own applications.

Reports

367

Serious

226

62% of reports

Hospitalization

52

Death reported

23

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective36
  • hypotension30
  • hypoxia27
  • ventilation perfusion mismatch25
  • oxygen saturation decreased18
  • tachycardia17
  • atrial fibrillation15
  • bradycardia13
  • extravasation13
  • blood pressure inadequately controlled11
  • off label use11
  • infusion site extravasation10
  • blood triglycerides increased9
  • drug administration error9
  • no adverse event8

Reports by year received

View as table
YearReports
20071
200977
201018
201112
20125
20133
201417
201512
201625
20177
201821
201925
202029
202116
202224
202327
202420
202517
202611

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,792 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
ventilation perfusion mismatchSignal255602.33763.8122,500
extravasationSignal13181.9106.52,154
blood pressure inadequately controlledSignal11105.058.61,030
infusion site extravasationSignal1092.250.0812
hypoxiaSignal2744.030.61,092
blood triglycerides increasedSignal929.215.3218
oxygen saturation decreasedSignal1818.411.7279
drug administration errorSignal916.88.8119
bradycardiaSignal1314.18.2145
tachycardiaSignal1711.06.9145
atrial fibrillationSignal158.85.497
hypotensionSignal308.66.1195
no adverse eventSignal82.51.36
drug ineffective361.61.17
off label use110.70.41

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.